Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,950
datasets available to search
ShareScore release 0.9.0
Dataset results
10,950 results for “hosting”
Detection of Graft Versus Host Disease With [18F]F-AraG
ClinicalTrials.gov study NCT03367962. IPD Sharing: NO. Countries: 1. Publications: 0.
Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED)
ClinicalTrials.gov study NCT03298815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT01491958. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)
ClinicalTrials.gov study NCT00675441. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
ClinicalTrials.gov study NCT00568633. IPD Sharing: NO. Countries: 1. Publications: 0.
Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids
ClinicalTrials.gov study NCT00489216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
ClinicalTrials.gov study NCT04425252. IPD Sharing: NO. Countries: 1. Publications: 0.
Psychosocial Mobile App for Chronic Graft-Versus-Host Disease
ClinicalTrials.gov study NCT05690971. IPD Sharing: YES. Countries: 1. Publications: 0.
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
ClinicalTrials.gov study NCT00975975. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
ClinicalTrials.gov study NCT01116232. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
ClinicalTrials.gov study NCT01525407. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic
ClinicalTrials.gov study NCT02500550. IPD Sharing: NO. Countries: 6. Publications: 0.
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
ClinicalTrials.gov study NCT07124078. IPD Sharing: YES. Countries: 6. Publications: 0.
The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye
ClinicalTrials.gov study NCT00553735. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
ClinicalTrials.gov study NCT02701634. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.
ClinicalTrials.gov study NCT07162688. IPD Sharing: NO. Countries: 1. Publications: 0.
Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment
ClinicalTrials.gov study NCT00079183. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)
ClinicalTrials.gov study NCT02040623. IPD Sharing: NO. Countries: 1. Publications: 0.
Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Mar
ClinicalTrials.gov study NCT00343785. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients
ClinicalTrials.gov study NCT07297303. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.